A detailed history of Dimensional Fund Advisors LP transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 479,936 shares of NAUT stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
479,936
Previous 401,025 19.68%
Holding current value
$1.09 Million
Previous $1.2 Million 17.68%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.41 - $3.18 $190,175 - $250,936
78,911 Added 19.68%
479,936 $1.41 Million
Q4 2023

Feb 07, 2024

BUY
$2.34 - $3.39 $369,890 - $535,867
158,073 Added 65.06%
401,025 $1.2 Million
Q3 2023

Nov 09, 2023

BUY
$2.87 - $3.94 $467,784 - $642,184
162,991 Added 203.84%
242,952 $767,000
Q2 2023

Aug 09, 2023

BUY
$2.21 - $4.52 $117,331 - $239,971
53,091 Added 197.58%
79,961 $309,000
Q1 2023

May 12, 2023

BUY
$1.67 - $2.77 $44,872 - $74,429
26,870 New
26,870 $74,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $283M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.